[Effect of cerebrolysin on remyelination processes in multiple sclerosis patients in stage of relapse regression].

@article{Khabirov2016EffectOC,
  title={[Effect of cerebrolysin on remyelination processes in multiple sclerosis patients in stage of relapse regression].},
  author={Farit A. Khabirov and T I Khaybullin and Evgenii V. Granatov and S R Shakirzianova},
  journal={Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova},
  year={2016},
  volume={116 12},
  pages={48-53}
}
AIM To evaluate the efficacy and safety of Cerebrolysin (EVER Neuro Pharma GmbH, Austria) in the treatment of patients with multiple sclerosis (MS) in stage of relapse regression. MATERIAL AND METHODS The study involved 40 patients with remitting MS (McDonald criteria 2010) in stage of MS relapse regression after pulse therapy with methylprednisolone 1000 mg/day 5. Patients randomized into 2 groups: group 1 (G1, n=20) received cerebrolysin 20 ml per 200 ml of 0.9% NaCl solution 1 times per… CONTINUE READING